Short Interest in Streamline Health Solutions Inc. (NASDAQ:STRM) Expands By 147.8%

Streamline Health Solutions Inc. (NASDAQ:STRM) was the target of a significant growth in short interest during the month of August. As of August 31st, there was short interest totalling 11,400 shares, a growth of 147.8% from the July 31st total of 4,600 shares. Based on an average daily trading volume, of 28,700 shares, the days-to-cover ratio is presently 0.4 days. Currently, 0.1% of the company’s stock are short sold.

In other Streamline Health Solutions news, CEO David William Sides sold 51,095 shares of the business’s stock in a transaction on Monday, June 17th. The stock was sold at an average price of $1.77, for a total value of $90,438.15. Following the sale, the chief executive officer now directly owns 225,000 shares of the company’s stock, valued at $398,250. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 24.28% of the stock is currently owned by insiders.

Several hedge funds and other institutional investors have recently modified their holdings of STRM. Alera Investment Advisors LLC grew its holdings in shares of Streamline Health Solutions by 2,084.2% during the first quarter. Alera Investment Advisors LLC now owns 103,750 shares of the company’s stock valued at $109,000 after buying an additional 99,000 shares during the last quarter. Vanguard Group Inc. raised its holdings in Streamline Health Solutions by 53.3% in the 2nd quarter. Vanguard Group Inc. now owns 177,001 shares of the company’s stock worth $267,000 after acquiring an additional 61,550 shares during the last quarter. Renaissance Technologies LLC raised its holdings in Streamline Health Solutions by 2.4% in the 2nd quarter. Renaissance Technologies LLC now owns 351,250 shares of the company’s stock worth $530,000 after acquiring an additional 8,300 shares during the last quarter. Finally, Tamarack Advisers LP lifted its position in Streamline Health Solutions by 7.7% in the 2nd quarter. Tamarack Advisers LP now owns 2,100,000 shares of the company’s stock valued at $3,276,000 after acquiring an additional 150,000 shares in the last quarter. Hedge funds and other institutional investors own 41.79% of the company’s stock.



Separately, ValuEngine raised Streamline Health Solutions from a “hold” rating to a “buy” rating in a research report on Friday, May 24th.

STRM stock traded up $0.15 during trading on Wednesday, hitting $1.54. 42,243 shares of the stock traded hands, compared to its average volume of 19,503. Streamline Health Solutions has a 1 year low of $0.57 and a 1 year high of $2.09. The firm’s 50 day moving average is $1.42 and its two-hundred day moving average is $1.31. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.63 and a current ratio of 0.63.

Streamline Health Solutions (NASDAQ:STRM) last issued its earnings results on Wednesday, June 12th. The company reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.01). The firm had revenue of $5.36 million during the quarter. Streamline Health Solutions had a negative return on equity of 20.57% and a negative net margin of 23.23%.

Streamline Health Solutions Company Profile

Streamline Health Solutions, Inc provides health information technology solutions and services for hospitals and health systems in the United States and Canada. It provides software-based solutions and auditing services, which captures, aggregates, and translates structured and unstructured data to deliver predictive insights to its clients.

See Also: What is insider trading?

Receive News & Ratings for Streamline Health Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Streamline Health Solutions and related companies with MarketBeat.com's FREE daily email newsletter.